Your browser doesn't support javascript.
loading
CXCL13 Levels Indicate Treatment Responsiveness to Fingolimod in MS Patients.
Karaaslan, Zerrin; Kurtuncu, Murat; Akcay, Halil Ibrahim; Gunduz, Tuncay; Altunrende, Burcu; Turkoglu, Recai; Eraksoy, Mefkure; Ulusoy, Canan; Yilmaz, Vuslat; Tüzün, Erdem.
Afiliação
  • Karaaslan Z; Department of Neuroscience, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey, zkaraaslan@gmail.com.
  • Kurtuncu M; Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
  • Akcay HI; Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
  • Gunduz T; Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
  • Altunrende B; Department of Neurology, Faculty of Medicine, Demiroglu Bilim University, Istanbul, Turkey.
  • Turkoglu R; Department of Neurology, Istanbul Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.
  • Eraksoy M; Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
  • Ulusoy C; Department of Neuroscience, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
  • Yilmaz V; Department of Neuroscience, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
  • Tüzün E; Department of Neuroscience, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
Eur Neurol ; 85(1): 69-71, 2022.
Article em En | MEDLINE | ID: mdl-34340233
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cloridrato de Fingolimode / Esclerose Múltipla Limite: Humans Idioma: En Revista: Eur Neurol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cloridrato de Fingolimode / Esclerose Múltipla Limite: Humans Idioma: En Revista: Eur Neurol Ano de publicação: 2022 Tipo de documento: Article